This study analyzed the risk factors of premature CI and found that CYP2C19 IM + PM phenotype, history of smoking, hypertension, diabetes mellitus, and dyslipidemia were risk factors for premature CI. This evidence concerns the gene CYP2C19 and metabolic syndrome.